trimethoprim 200mg tablets
sandoz ltd - trimethoprim - oral tablet - 200mg
trimethoprim 200mg tablets
almus pharmaceuticals ltd - trimethoprim - oral tablet - 200mg
trimethoprim 50mg/5ml oral suspension sugar free
pinewood healthcare - trimethoprim - oral suspension - 10mg/1ml
trimethoprim 200mg tablets
phoenix healthcare distribution ltd - trimethoprim - oral tablet - 200mg
trimethoprim 200mg tablets
accord-uk ltd - trimethoprim - oral tablet - 200mg
trimethoprim 200mg tablets
waymade healthcare plc - trimethoprim - oral tablet - 200mg
trimethoprim 200mg tablets
crescent pharma ltd - trimethoprim - oral tablet - 200mg
trimethoprim 200mg tablets
mawdsley-brooks & company ltd - trimethoprim - oral tablet - 200mg
polymyxin b sulfate and trimethoprim sulfate- polymyxin b sulfate, trimethoprim sulfate solution/ drops
quality care products llc - polymyxin b sulfate (unii: 19371312d4) (polymyxin b - unii:j2vz07j96k), trimethoprim sulfate (unii: e377mf8eq8) (trimethoprim - unii:an164j8y0x) - polymyxin b 10000 [usp'u] in 1 ml - polymyxin b sulfate and trimethoprim ophthalmic solution, usp is indicated in the treatment of surface ocular bacterial infections, including acute bacterial conjunctivitis, and blepharoconjunctivitis, caused by susceptible strains of the following microorganisms: staphylococcus aureus, staphylococcus epidermidis, streptococcus pneumoniae, streptococcus viridans, haemophilus influenzae and pseudomonas aeruginosa.* *efficacy for this organism in this organ system was studied in fewer than 10 infections. polymyxin b sulfate and trimethoprim ophthalmic solution, usp is contraindicated in patients with known hypersensivitity to any of its components.
polymyxin b sulfate and trimethoprim sulfate- polymyxin b sulfate, trimethoprim sulfate solution/ drops
pacific pharma, inc. - polymyxin b sulfate (unii: 19371312d4) (polymyxin b - unii:j2vz07j96k), trimethoprim sulfate (unii: e377mf8eq8) (trimethoprim - unii:an164j8y0x) - polymyxin b 10000 [usp'u] in 1 ml - polymyxin b sulfate and trimethoprim ophthalmic solution, usp is indicated in the treatment of surface ocular bacterial infections, including acute bacterial conjunctivitis, and blepharoconjunctivitis, caused by susceptible strains of the following microorganisms: staphylococcus aureus, staphylococcus epidermidis, streptococcus pneumoniae, streptococcus virida ns , haemophilus influenzae and pseudomonas aeruginosa.* *efficacy for this organism in this organ system was studied in fewer than 10 infections. polymyxin b sulfate and trimethoprim ophthalmic solution, usp is contraindicated in patients with known hypersensitivity to any of its components.